Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 7/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 6/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | G6PD | P11413 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | MAX | P61244 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | SI | P14410 | 2/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26020993 | 0.93 | MAPT (0.51) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL13271195 | 0.84 | ACHE (0.75) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL31643056 | 0.83 | RAB9A (0.53) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL20475325 | 0.83 | RAB9A (0.53) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL13271231 | 0.82 | ACHE (0.65) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL183009 | 0.81 | NQO2 (0.57) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL20272058 | 0.81 | ACHE (0.69) | NQO2ACHEMAPTRAB9AGAA | |
| Bromide SCHEMBL11421481 | 0.79 | NQO2 (0.55) | NQO2ACHEMAPTRAB9AGAA | |
| SCHEMBL17483582 | 0.79 | NQO2 (0.68) | NQO2MAPTRAB9AGAAALDH1A1 | |
| SCHEMBL17483584 | 0.79 | NQO2 (0.68) | NQO2MAPTRAB9AGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| EP-4107147-A1 | NOVEL PHENAZINE-BASED COMPOUNDS | CMBlu Energy AG (DE) | 2022-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731945-B2 | Redox-active compounds and uses thereof | NOX4, NQO1, GPX1 | NQO2 519/4885ACHE 498/4885MAPT 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.